论文部分内容阅读
目的:分析欣母沛与米索前列醇预防行剖宫产术的高危产妇产后出血的临床应用效果。方法:选择我院2016年1月到2017年1月行剖宫产术的高危产妇100例为研究对象,在签署知情同意书情况下按照数字随机分配原则将患者分为对照组和观察组,各50例。观察给予欣母沛预防治疗,对照组给予索前列醇预防治疗,比较两组患者产后出血及不良反应情况。结果:观察组产妇术中出血量及术后两小时出血量均少于对照组,两组比较差异显著,P<0.05。两组对比,观察组产妇不良反应发生率要显著低于对照组,差异显著,有统计学意义,P<0.05。讨论:为保障高危产妇生命安全,对实施剖宫产的高危产妇给予肌肉注射欣母沛可预防其产后出血,减少产妇死亡率,同时还能降低其不良反应发生率,值得临床推广。
Objective: To analyze the clinical effect of Xin-Pei-Pei and misoprostol in preventing high-risk maternal postpartum hemorrhage in cesarean section. Methods: 100 cases of high-risk maternal women who underwent cesarean section from January 2016 to January 2017 in our hospital were selected as research subjects. Patients were divided into control group and observation group according to the principle of random distribution under the condition of signed informed consent. 50 cases each. Observed to give Yan-Pei prevention and treatment, the control group were given prophylaxis and treatment of propofol, postpartum hemorrhage and adverse reactions in both groups were compared. Results: The amount of bleeding in the observation group and the amount of bleeding in two hours after operation were all less than those in the control group. There was significant difference between the two groups (P <0.05). The two groups, the observation group maternal adverse reaction rate was significantly lower than the control group, the difference was significant, statistically significant, P <0.05. Discussion: In order to protect the safety of high-risk maternal life, intramuscular injection of Xin-Pei given to high-risk maternal women at cesarean section can prevent postpartum hemorrhage and reduce maternal mortality while reducing the incidence of adverse reactions and is worthy of clinical promotion.